VEGFR1 and VEGFR2

BIOLOGICAL3 trials

Sponsors

Tokyo University, Osaka University

Conditions

Age Related Macular DegenerationBreast CancerColon CancerColorectal CancerNeovascular MaculopathyRectal Cancer

Phase 1

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer

TerminatedNCT00677326

Tokyo UniversityBreast Cancer

Start: 2008-05-31End: 2009-05-31Updated: 2009-12-29

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer

TerminatedNCT00677612

Tokyo UniversityColon Cancer, Colorectal Cancer, Rectal Cancer

Start: 2008-05-31End: 2009-03-31Target: 14Updated: 2009-12-29

Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy

CompletedNCT00791570

Osaka UniversityAge Related Macular Degeneration, Neovascular Maculopathy

Start: 2008-10-31End: 2012-04-30Updated: 2012-10-16